AKT1 and breast carcinoma: In this regard, Yi Yu et al. have shown that ARQ 092 and ARQ 751 can inhibit the activation of AKT by actively forming and destroying the ion-membrane metastasis pathway and have a better curative effect on breast cancer cells with AKT1-E17K mutations (36).